tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market

JW (Cayman) Therapeutics Co. Ltd. (2126) Income Statement

Compare
0 Followers

JW (Cayman) Therapeutics Co. Ltd. Income Statement

Last quarter (Q4 2024), JW (Cayman) Therapeutics Co. Ltd.'s total revenue was ¥71.40M, a decrease of -10.40% from the same quarter last year. In Q4, JW (Cayman) Therapeutics Co. Ltd.'s net income was ¥-350.36M. See JW (Cayman) Therapeutics Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 158.22M¥ 173.86M¥ 145.70M¥ 30.80M¥ 0.00
Gross Profit
¥ 77.32M¥ 88.22M¥ 58.76M¥ 9.04M¥ 0.00
Operating Expenses
¥ 536.60M¥ 877.83M¥ 914.64M¥ 716.98M¥ 1.67B
Depreciation and Amortization
¥ 77.45M¥ 99.83M¥ 87.07M¥ 48.23M¥ 13.82M
EBITDA
¥ -381.58M¥ -655.75M¥ -752.27M¥ -738.70M¥ -454.04M
Operating Income
¥ -459.28M¥ -789.61M¥ -697.17M¥ -771.72M¥ -467.86M
Other Income/Expenses
¥ -131.34M¥ 21.61M¥ 9.75M¥ 56.76M¥ -1.20B
Pretax Income
¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M¥ -1.66B
Net Income
¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M¥ -1.66B
Per Share Metrics
Basic EPS
¥ -1.43¥ -1.87¥ -2.06¥ -1.76¥ -12.61
Diluted EPS
¥ -1.43¥ -1.87¥ -2.06¥ -1.76¥ -12.61
Weighted Average Shares Outstanding
413.63M 411.53M 410.09M 399.75M 131.90M
Weighted Average Shares Outstanding (Diluted)
413.63M 411.53M 410.09M 399.75M 131.90M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis